BioCentury | Nov 15, 2004
Clinical News

Bionomics preclinical data

...In a xenograft mouse model of breast cancer, BN069, a gene silencing molecule, reduced tumor size...
...and the Discovery on Target meeting in Boston. Bionomics Ltd. (ASX:BNO; BMICY), Thebarton, Australia Product: BN069...
BioCentury | Aug 16, 2004
Company News

Bionomics other research news

Researchers published in the Proceedings of the National Academy of Sciences data that suggest BNO69 inhibitors would block angiogenesis. Bionomics Ltd. (ASX:BNO; BMICY), Adelaide, Australia, et al. Product: BNO69 Use: Treat cancer WIR Staff cancer...
Items per page:
1 - 2 of 2